These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23180358)

  • 1. Laboratory testing for prescription opioids.
    Milone MC
    J Med Toxicol; 2012 Dec; 8(4):408-16. PubMed ID: 23180358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of oral fluid in compliance monitoring of opioid medications.
    Conermann T; Gosalia AR; Kabazie AJ; Moore C; Miller K; Fetsch M; Irvan D
    Pain Physician; 2014; 17(1):63-70. PubMed ID: 24452646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of urine drug testing for patients on opioid therapy.
    Pergolizzi J; Pappagallo M; Stauffer J; Gharibo C; Fortner N; De Jesus MN; Brennan MJ; Richmond C; Hussey D;
    Pain Pract; 2010; 10(6):497-507. PubMed ID: 20412503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the utility of urine- and hair testing in detecting self-reported drug use among young adult opioid users.
    Palamar JJ; Le A; Guarino H; Mateu-Gelabert P
    Drug Alcohol Depend; 2019 Jul; 200():161-167. PubMed ID: 31146203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoassay in healthcare testing applications.
    DePriest AZ; Black DL; Robert TA
    J Opioid Manag; 2015; 11(1):13-25. PubMed ID: 25750161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine and oral fluid drug testing in support of pain management.
    Kwong TC; Magnani B; Moore C
    Crit Rev Clin Lab Sci; 2017 Sep; 54(6):433-445. PubMed ID: 28990451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
    Atluri S; Sudarshan G; Manchikanti L
    Pain Physician; 2014; 17(2):E119-28. PubMed ID: 24658483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of U-47700, a Novel Synthetic Opioid, in Human Urine by LC-MS-MS and LC-QToF.
    Fleming SW; Cooley JC; Johnson L; Frazee CC; Domanski K; Kleinschmidt K; Garg U
    J Anal Toxicol; 2017 Apr; 41(3):173-180. PubMed ID: 28035035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a lateral flow immunoassay for the detection of the synthetic opioid fentanyl.
    Angelini DJ; Biggs TD; Maughan MN; Feasel MG; Sisco E; Sekowski JW
    Forensic Sci Int; 2019 Jul; 300():75-81. PubMed ID: 31078080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
    Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ
    Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of codeine positivity in urine of pain management patients.
    Colby JM; Wu AH; Lynch KL
    J Anal Toxicol; 2015 Jun; 39(5):407-10. PubMed ID: 25840440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic.
    Faller RW; Erausquin JT; McCoy TP
    Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317
    [No Abstract]   [Full Text] [Related]  

  • 19. Anodyne by Design; Measuring the Prevalence of Esoteric Designer Opioids in Pain Management Patients.
    Goggin MM; Gozum SD; Miller A; Janis GC
    J Anal Toxicol; 2018 Jul; 42(6):384-391. PubMed ID: 29471504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine Drug Testing among Opioid-Naïve and Long-Term Opioid Nevada Medicaid Beneficiaries.
    Friedman S; Patel K; Liu Y; Hartzell S; Keller MS
    Subst Use Misuse; 2020; 55(14):2314-2320. PubMed ID: 32835582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.